Health
New drug candidate to fight COVID-19 – Goondiwindi Argus
A drug described as potential new immunotherapy for COVID-19 will enter a clinical trial in the USA led by former Australian of the Year Professor Ian Frazer.
A drug described as potential new immunotherapy for COVID-19 will enter a clinical trial in the USA led by former Australian of the Year Professor Ian Frazer.
Developed by Brisbane and Seattle-based company, Implicit Bioscience, the drug IC14 will this week be tested in COVID-19 patients in 10-15 hospitals across the United States.
The new drug, for which Prof Frazer is the clinical immunologist and chief scientific officer, will treat immune responses to COVID-19 and its health complications.
Its…
-
General16 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business23 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General23 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips
-
General7 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay